Skip to main content

Advertisement

Log in

Intravitreal ranibizumab (Lucentis) for choroidal neovascularization associated with Stargardt’s disease

  • Case Report
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

To describe a young patient with choroidal neovascularization, associated with Stargardt’s disease, who underwent treatment with intravitreal ranibizumab.

Methods

A 26-year-old man with a diagnosis of Stargard’s disease presented at our department for sudden decreased vison in his right eye (20/800). Upon a complete oplthamologic examination, including fluorescein angiography (FA), indocyanine green angiography (ICGA) and optical coherence tomography (OCT), the patient was diagnosed with subfoveal CNV of the right eye. Owing to the subfoveal localization of the CNV, intravitreal ranibizumab injection was performed on this young patient.

Results

Three months after the last intravitreal injection of ranibizumab, fundus biomicroscopy, FA, ICGA and OCT revealed the CNV closure and total resolution of the associated cistoid macular edema and serous retinal detachment, with no recurrence and no complication from the intravitreal injection of ranibizumab. Visual acuity improved only to 20/400.

Conclusion

Intravitreal ranibizumab injection seems to induce total regression of CNV complicating Stargardt’s disease. Further investigations are required to confirm our results.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Stargardt K (1909) Ueber familiare progressive Degeneration in der Makulagegend des Auges. Albrecht Von Graefes Arch Ophthalmol 71:534–50

    Google Scholar 

  2. Cibis GW, Morey M, Karris DJ (1980) Dominantly inherited macular dystrophy with flecks (Stargardt). Arch Ophthalmol 98:1785

    PubMed  CAS  Google Scholar 

  3. Merlin S, Landau J (1970) Abnormal findings in relatives of patients with juvenile hereditary macular degeneration (Stargardt’s disease). Ophthalmologica 161:1

    Article  Google Scholar 

  4. Allikmets R, Singh N, Sun H et al (1997) A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet 15:236–46

    Article  PubMed  CAS  Google Scholar 

  5. Cremers FP, van de Pol DJ, van Driel M et al (1998) Autosomal recessive retinitis pigmentosa and cone-rod dystrophy caused by splice site mutations in the Stargardt’s disease gene ABCR. Hum Mol Genet 7:355–62

    Article  PubMed  CAS  Google Scholar 

  6. Rozet JM, Gerber S, Souied E et al (1998) Spectrum of ABCR gene mutations in autosomal recessive macular dystrophies. Eur J Hum Genet 6:291–5

    Article  PubMed  CAS  Google Scholar 

  7. Klein R, Lewis RA, Meyers SM, Myers FL (1978) Subretinal neovascularization associated with fundus flavimaculatus. Arch Ophthalmol 96:2054–2057

    PubMed  CAS  Google Scholar 

  8. Rosenfeld PJ, Brown DM, Heier JS et al (2006) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355:1419–1431

    Article  PubMed  CAS  Google Scholar 

  9. Brown DM, Kaiser PK, Michels M et al (2006) Ranibizumab vs verteporfin for neovascular age-related macular degeneration. N Engl J Med 355:1432–1444

    Article  PubMed  CAS  Google Scholar 

  10. Souied EH, Pawlak D, Algan M et al (2005) Photodynamic therapy for choroidal neovascularization on late-onset fundus flavimaculatus. Am J Ophthalmol 140:312–4

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Giuseppe Querques.

Additional information

The authors have no proprietary interest in the materials used in this study.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Querques, G., Bocco, M.C.A., Soubrane, G. et al. Intravitreal ranibizumab (Lucentis) for choroidal neovascularization associated with Stargardt’s disease. Graefes Arch Clin Exp Ophthalmol 246, 319–321 (2008). https://doi.org/10.1007/s00417-007-0689-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-007-0689-z

Keywords

Navigation